Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

exact-rx, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 60 mg in 1 g - for dermatologic use: sa 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). for podiatric use: sa 6% is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. sa 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. sa 6% should not be used in children under 2 years of age.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

the honest company, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 2 g in 100 g - acne treatment gel for the treatment of acne

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

kate somerville skincare, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.5 g in 100 ml

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

kate somerville skincare, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.5 g in 100 ml

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

the proactiv company llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.5 g in 100 ml - acne treatment for the management of acne.                  - irritation becomes severe

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

halogent, llc (dba exposed skin care) - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.5 g in 100 ml - purpose acne treatment use for the treatment of acne

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

j. a. cosmetics u.s. inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.5 g in 100 ml - purpose: acne treatment uses: - for treatment of acne  - helps prevent new acne blemishes

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

aspire brands inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.5 g in 100 ml - acne treatment acne treatment to help clear up and prevent new acne blemishes, blackheads, and whiteheads.

Европска Унија - Енглески - EMA (European Medicines Agency)

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Европска Унија - Енглески - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy